CBT vs KRO

For growth investors, Kronos Worldwide, Inc.

(KRO) is the stronger pick with -1. 5% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Cabot Corporation (CBT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +43.

8%, compared to -40. 9% for Kronos Worldwide, Inc. (KRO). Over 10 years, the gap is even starker: KRO returned +121. 1% versus CBT's +115. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.

78β versus Kronos Worldwide, Inc. 's 1. 57β — meaning KRO is approximately 101% more volatile than CBT relative to the S&P 500. On balance sheet safety, Cabot Corporation (CBT) carries a lower debt/equity ratio of 71% versus 77% for Kronos Worldwide, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Kronos Worldwide, Inc.

(KRO) is pulling ahead at -1. 5% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Cabot Corporation grew EPS -10. 4% year-over-year, compared to -228. 0% for Kronos Worldwide, Inc.. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cabot Corporation (CBT) is the more profitable company, earning 8.

9% net margin versus -6. 0% for Kronos Worldwide, Inc. — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus -1. 7% for KRO. At the gross margin level — before operating expenses — CBT leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for CBT: -5.

4% to $78. 00.

All stocks in this comparison pay dividends.

Kronos Worldwide, Inc. (KRO) offers the highest yield at 2. 6%, versus 2. 1% for Cabot Corporation (CBT).

For long-horizon retirement investors, Cabot Corporation (CBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

78), 2. 1% yield, +115. 6% 10Y return). Kronos Worldwide, Inc. (KRO) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CBT: +115. 6%, KRO: +121. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CBT is a small-cap deep-value stock; KRO is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.